 Hemorheologic coagulative pattern hypercholesterolemic subjects lipid-lowering drugs effects coagulative rheologic pattern lipid-lowering drugs bezafibrate simvastatin hypercholesterolemic subjects Patients groups subjects bezafibrate mg/day mg/day twelve week period decrease plasma fibrinogen bezafibrate reduction factor VIIc VIIIc activity antithrombin activity hemorheologic pattern Simvastatin slight decrease factor VIIIc activity moderate reduction beta-thromboglobulin efficacy bezafibrate activation coagulative cascade hemorheologic pattern peculiar triglycerides- fibrinogen-lowering effect drug simvastatin responsible modifications